Report Wire - Covaxin recognised by UK govt as legitimate Covid-19 vaccine from Nov 22

Report Wire

News at Another Perspective

Covaxin recognised by UK govt as legitimate Covid-19 vaccine from Nov 22

2 min read
Covaxin recognised by UK govt as valid Covid-19 vaccine from Nov 22

On Monday (November 22), the United Kingdom recognised India’s indigenous Coronavirus vaccine Covaxin as legitimate within the nation.
In an announcement launched by the UK authorities, it stated, “From 4am on Monday 22 November, the government will recognise vaccines on the World Health Organization’s Emergency Use Listing (WHO EUL). As a result, Sinovac, Sinopharm Beijing and Covaxin will be added to our list of approved vaccines for inbound travel, benefitting more fully vaccinated people from countries such as the United Arab Emirates, Malaysia and India.”
It added, “Sinovac, Sinopharm Beijing and Covaxin are covered by the expansion to the WHO EUL, and around 1 billion doses of these vaccines have been delivered worldwide.” On November 8, the British High Commissioner to India, Alex Hales had knowledgeable, “From 22 November travellers fully vaccinated with a #COVID19 vaccine recognised by @WHO for Emergency Use Listing, including Covaxin, will not have to self-isolate; so joining those fully vaccinated with Covishield.”
More excellent news for 🇮🇳 travellers to 🇬🇧👇From 22 November travellers totally vaccinated with a #COVID19 vaccine recognised by @WHO for Emergency Use Listing, together with Covaxin, is not going to must self-isolate; so becoming a member of these totally vaccinated with Covishield.— Alex Ellis (@AlexWEllis) November 8, 2021
As such, Indians who’ve obtained double doses (totally vaccinated) of Covaxin and have the related Covid-19 certificates will likely be exempted from a pre-departure Covid-19 check. They may also be not required to self-isolate on arrival within the UK or endure testing on Day 8. However, they might want to undertake a lateral movement check earlier than the top of the second day of their go to to the UK. As of now, the United Kingdom has recognised the next vaccines. now embrace Oxford-AstraZeneca (Covishield), Moderna, Janssen, Pfizer BioNTech, Sinovac, Sinopharm Beijing and Covaxin.
WHO accredited Bharat Biotech’s Covaxin, granted it Emergency Use Listing standing
The World Health Organization (WHO) on November 3 granted the Emergency Use Listing standing to Covaxin after the Technical Advisory Group of WHO really helpful the identical. In a tweet thread, WHO stated the Technical Advisory Group (TAG), an unbiased advisory committee of the World Health Organisation (WHO), has really helpful Emergency Use Listing (EUL) standing for Covaxin, the Covid-19 vaccine manufactured by India’s Bharat Biotech.
It additional added, “The Technical Advisory Group, convened by WHO and made up of regulatory experts from around the world, has determined that the #Covaxin vaccine meets WHO standards for protection against #COVID19, that the benefit of the vaccine far outweighs risks & the vaccine can be used Earth globe Europe-Africa.”